Patient-Reported Outcomes of GI Symptoms and Adherence Among Pediatric Patients Using a Pea Protein Plant-Based Enteral Formula1

Authors: Stanley Cohen, MD; Dwan Newman, RD, LDN, CNSC; Ana Ramirez, MD; Vanessa Millovich, DCN, RDN, LDN

Abstract presented at North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition (NASPGHAN) 2020 and published in the supplement of the Journal of Pediatric Gastroenterology and Nutrition.

The purpose of this study was to describe the specific symptom frequency of constipation, diarrhea, vomiting, bloating and adherence reported in pediatric patients who have been on a pea protein plant-based enteral formula (PP PBEF). Pediatric patients between the ages of 1-20 years old or their caregivers completed an electronic survey (n=159).

Patients who switched to Kate Farms reported improved tolerance, weight gain, and adherence.

  • Episodes of constipation, bloating, vomiting and diarrhea decreased by 35-45%

  • 90.6% gained or maintained weight

  • 89.6% adherence compared to 48.4% on previous formula2

References

1. Cohen, SA., Newman, D., Ramirez, A., Millovich, V. Patient-Reported Outcomes of GI Symptoms and Adherence Among Pediatric Patients Using a Pea Protein Plant-Based Enteral Formula. JPGN.2020; 71(Supp1): S454-456.

2. Adherence defined as consuming > 75% of the formula prescribed (n=159).